Jul 23 2014
According to the World Health Organization (WHO), more than 1 million people acquire a sexually transmitted infection every day. Organizations including the WHO have called on countries to create screening programs to combat the spread of these infections in a convenient, cost efficient, and timely manner. Traditional testing methods involve individual tests for each virus with a turnaround time of several days up to a week, which increases the cost to labs and wastes precious time for patients. With MedMira’s multiplex capable Multiplo tests, healthcare professionals can instantly screen for multiple disease states in several combinations using a single cartridge.Read More
Jun 27 2014
The CDC estimates that 1.1 million people in the United States are living with HIV. An alarming one in six of people do not know that they carry the infection. National HIV Testing Day serves as a reminder to us all of the importance of HIV screening and implementing cost-effective programs in an effort to stop the spread of this disease.Read More
May 15 2014
Rapid testing reinvented. That’s MedMira’s message as it looks to expand its presence in China where the size of the in vitro diagnostics (IVD) market is expected to grow by 20 percent each year.
Apr 15 2014
Does point-of-care (POC) diagnostic testing differ depending on your region of the world?
Mar 28 2014
Europe has seen growing pressure to make HIV testing more accessible, as HIV is often undiagnosed or diagnosed too late in the course of the disease. Moreover, HIV infection rates in Europe have increased nearly eight percent since 2011, particularly in the East where 44 percent of new infections were reported.
Mar 10 2014
While the clinical healthcare market has had access to point-of-use testing for quite some time, there has never been a real-time analytical tool that researchers could use outside of lab settings to facilitate mobile antigen and antibody detection. Instead, they have long relied on traditional analyte testing technologies such as the ELISA and Western blot, which are technically challenging, inefficient and require a variety of components.
Feb 23 2014
Since MedMira was established in 1993, we have been dedicated to fulfilling our vision of transforming point-of-use testing by delivering the instant; reliable results healthcare providers need to make critical treatment decisions. I founded MedMira on this promise and for the last two decades, we have provided people all over the world with life-saving diagnostics that are helping people know.Read More